Der wandel des spektrums uteruserhaltender myomoperationen unter einbeziehung von endoskopie und dualer myomtherapie

Gynakologisch-geburtshilfliche Rundschau

Volumn 36, Issue 3, 1996, Pages 118-132

  Wallwiener, D ^a   Aydeniz, B ^a   Rimbach, S ^a   Diel, I J ^a   Grischke, E M ^a   Rabe, T ^a   Bastert, G ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Endoscopy; GnRH analogues; Myoma; Organ preservation

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; GERMANY; HUMAN; HYSTERECTOMY; HYSTEROSCOPE; HYSTEROSCOPY; INCIDENCE; INSTRUMENTATION; LAPAROSCOPE; LAPAROSCOPY; LEIOMYOMA; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME; UTERUS CANCER; UTILIZATION REVIEW; VIDEORECORDING;

ADULT; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HUMANS; HYSTERECTOMY; HYSTEROSCOPES; HYSTEROSCOPY; INCIDENCE; LAPAROSCOPES; LAPAROSCOPY; LEIOMYOMA; TREATMENT OUTCOME; UTERINE NEOPLASMS; VIDEO RECORDING;

EID: 0030342789     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000272638     Document Type: Article

References (47)

1. Altchek A: Management of uterine leiomyomata; in Altecheck A., Deligdisch L., (Hrsg): The Uterus: Pathology., Diagnosis, and Management., New York., Springer., 1992., pp 344-367.
2. Carr BR., Marshbum PB., Wcatherall PT., Bradshaw KD., Breslau NA, Byrd W., Boark M, Steinkampf MP: An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: A prospective, randomized, double-blind, placebo-controlled, crossover trial., J Clin Endocrinol Metab 1993;76:1217-1223.
3. Friedman AJ., Daly M, Juneau-Norcross M., Rein MS., Fine C, Gleason R, Leboff M: A prospective., randomized trial of gonadotropin-releasing hormone agonist plus estrogcn-pro-gestin or progestin ‘add-back’ regimens for women with leomyomata uteri., J Clin Endocrinol Metab 1993;76:1439-1445.
4. Golan A, Bukovsky I., Schneider D., Ron-El R., Herman A., Caspi E: D-Trp6 LH-RH microcapsules in the treatment of uterine leiomyomatas., Fértil Steril 1989;52:406-411.
5. Friedman AJ., Barbieri RL., Doubilct PM: A randomized, double-blind trial of gonadotropin-releasing hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri., Fértil Steril 1988;39:404-409.
6. Cirkcl U., Ochs H., Schneider HP., Mettler L., Mayer-Eichbergcr D., Schindler D., Schindler AE, Biihler K, Winkel U., Zahradnik HP, Ktin-zig HJ, Knak J., Patcrok E., Meinen K., Manca-rella D, Gerhard I., Lehmann F, Völker W: Experience with leuprorelin acetate depot in the treatment of fibroids: A German multi-centre study., Clin Ther 1992; 147A:37-50.
7. Mettler L: Laparoskopisches Vorgehen bei Myomenukleation nach Behandlung mit GnRH-Agonisten., 3rd Int Syrnp GnRH Analogues, Genf, Februar 1993., Kongressband Takeda Pharma, pp 4-6.
8. Wallwiener D., Aydcniz B, Rimbach S., Pollmann D, Sohn Ch., Kaden R, Bastert G: Myomtherapie: Minimal invasive Operationstechniken und GnRHa-Applikation., TW Gynäkol 1993:6:382-390.
9. Friedman AJ., Barbieri RL., Bcnacerraf BR., Schiff I: Treatment of leiomyomata with intranasal or subcutaneous leuprolide., a gonadotropin-releasing analog., Fertil Steril 1987:48:560-561.
10. Friedman AJ., Harrison-Atlas D., Barbieri RL., Benaccrraf BR., Gleason R., Schiff I: A randomized., placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata., Fertil Steril 1989:51:251-256.
11. Friedman AJ., Rein MS., Harrison-Atlas D., Garfield JM., Doubilet PM: A randomized, placebo-controlled double-blind study evaluating leuprolide acetate depot treatment before myomectomy., Fertil Steril 1989;52:728-733.
12. Golan A., Bukovsky L., Pansky M, Schneider D, Weintraub Z., Caspi E: Pre-operative gonadotrophin-releasing hormone agonist treatment in surgery for uterine leiomyomata., Hum Re-prod 1993;8:450-452.
13. Perino A, Chianchiano N, Petronio M., Citta-dini E: Role of leuprolide acetate depot in hys-tcroscopic surgery: A controlled study., Fertil Steril 1993:59:507.
14. Fedele L., Vercellini P., Bianchi S., Brioschi D., Dorta M: Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence., Br J Obstet Gynaecol 1990: 97:393-396.
15. Beyth Y: Gonadotropin-releasing hormone analog treatment should not recede conservative myomectomy., Fertil Steril 1990;53:187-188.
16. Dubuisson JF, Lecru F, Foulot H., Mandelbrot L., Aubriot FX., Mouiy M: Myomectomy by laparoscopy: A preliminary report of 43 cases., Fertil Steril 1993;56:827-830.
17. Dubuisson JF, Chapron C., Mouly M, Foulot H., Aubriot F: Laparoscopic myomectomy., Gynaecol Endosc 1993;2:171-173.
18. Friedman AJ., Daly M, Juneau-Norcross M., Fine C, Rein MS: Recurrence of myomas after myomectomy in women pretreated with leuprolide acetate depot or placebo., Fertil Steril 1992;58:205-208.
19. Wamsteker K., Emanuel MH., de Kruif JH: Transcervical hysteroscopic resection of sub-mucous fibroids for abnormal uterine bleeding: Results regarding the degree of intramural extension., Obstet Gynecol 1993:82:736-740.
20. Friedman AJ., Haas ST: Should uterine size be an indication for surgical intervention in women with myomas? Am J Obstct Gynecol 1993; 168:751-755.
21. Cirkel U: Uterus myomatosis: An den GnRH-Agoilisten führt kein Weig vorbei! 3rd lnt Syrnp GnRH Analogues., Genf., Februar 1993, Kongressband Takeda Pharma, pp 2-3.
22. Healy DL, Lawson SR., Abbott M., Baird DT., Fraser HM: Toward removing uterine fibroids without surgery: Subcutaneous infusion of a lutein., zing hormone-releasing hormone against commencing in the luteal phase., J Clin Endocrinol Metab 1986;63:619-625.
23. van Leusden HA: Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp6-LHRH., Lancet 1986: vol ii: 1213.
24. Coddington CC., Collins RL., Schawkcr TH: Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri., Fertil Steril 1986:45:624-629.
25. West CP., Lumsden MA, Lawson S., Williamson J., Bairdt DT: Shrinkage of uterine fibroids during therapy with oposcrelin (Zoladex): A LHRH agonist administered as a monthly subcutaneous depot., Fertil Steril 1987:48:45-51.
26. Lumsden MA, West CP, Bairdt DT: Goserelin therapy before surgery for uterine fibroids., Lancet 1987: vol i:36-41.
27. Andreyko JL, Blumenfeld Z, Marshall LA., Monroe SE, Hricak H., Jaffe RB: Use of an agonistic analog of gonadotropin-releasing hormone (nafrarelin) to treat leiomyomas: Assessment by magnetic resonance imaging., Am J Obstct Gynecol 1988;158:903-910.
28. Monroe SE., Andreyko J: Treatment of uterine leiomyomas and hirsutism with nafrarelin., J Rcprod Med 1989;34:1029-1033.
29. Schlaff WD., Zerhouni EA., Huth JAM., Chen J, Damewood MD, Rock JA: A placebo-con-trolled trial of a depot gonadotropin-releasing hormone analogue (Leuprolide) in the treatment of uterine leiomyomata., Obstct Gynecol 198974:856-862.
30. Hackcnbcrg R., Gescnhues T, Deichcrt U, Duda V., Sturm G, Schulz K-D: Präoperalive Reduktion von Uterusmyomen durch das GnRH-Analogon Goserclin (Zoladex")., Ge-burtsh Frauenheilkd 1990:50:136-139.
31. Friedman AJ., Hoffman DI, Comitc F, Browneller RW., Miller., ID: Treatment of leiomyomata uteri with leuprolidc acetate depot: A double-blind placebo-controlled, multieentcr study., Obslet Gynecol 1991:77:720-725.
32. Kiinzig HJ: Ergebnisse einer Multiccntcr-Stu-dic bei Uterus myomatosus mit Enantonc'-Gyn Monats-Depot; in Runncbaum B., Brcck-woldt M (Hrsg): Lcuprorclinacctat-Ein neues GnRH-Analogon., Grundlagen und Klinik., Berlin., Springer., 1992., pp 95-98.
33. Watanabe Y, Nakamura G., Matsuguchi H, No-zaki M., Sano M, Nakano H: Efficacy of a low-dosc leuprolidc acetate depot in the treatment of uterine leiomyomata in Japanese women., Fcrtil Steril 1992:58:66-71.
34. Boubli L., Blanc B., Barry B., Baulrant E: Treatment of LHRH agonist before hysteroscopic resection of myoma., Contracept Fcrtil Sex 1992:20:567-570.
35. Falsetti L., Mazzani MD., Rubessa S., Ruggieri C: Presurgical treatment of uterine fibroids by using gonadotropin-releasing hormone agonists., Acta Eur Fcrtil 1992;2371:29-32.
36. Biihler K: Sicherheitsaspekte der GnRH-Ago-nisten 3rd Int Symp GnRH Analogues., Genf., Februar 1993., Kongressband Takcda Pharma., p 10.
37. Maheux R., Lcmay A., Mérat P: Goscrclin therapy before surgery for uterine fibroids., Lancet 1987:vol i:36-37.
38. Massacesi M., Milkowski M., Gianfraneeschi C., Massacesi I: Short-term therapy of uterine fi-bromvomatosis with Gn-Rh analog., Minerva Gynecol 1992:44:641-644.
39. Donnez J, Nisolle M., Grandjcan P., Gillerot S., Clcrcky F: The role of GnRH agonists in the endoscopic treatment of endometriosis and myomas., Contracept Fertil Sex 1993;21:9-52.
40. Butram VC Jr., Reiter RC: Uterine leiomyomata: Etiology, symptomatology and management., Fertii Steril 1981:36:433-445.
41. Garcia CR., Tureck RW: Submucosal leiomyomas and infertility., Fcrtil Steril 1984:42:l6-19.
42. Candiani GB., Fedelc L., Parazzini F, Villa L: Risk of recurrence after myomectomy., Br.,1 Obstet Gynaecol 1991;98:385-389.
43. Kessel B., Liu J, Mortola J., Berga S., Yen SSC: Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone., Fertil Steril 1988;49:538-541.
44. Rein MS., Friedman AJ: Medical therapy for uterine leiomyomata; in Barbieri RI. Schiff I (Hrsg): Reproductive Endocrine Therapeutics., New York., Liss., 1988., pp 198-222.
45. Schwartz LB., Diamond MP., Schwartz PE: Leiomyosarcomas: Clinical presentation., Am J Obstet Gynecol 1993:168:180-183.
46. Smita S., Cooper M., Schinleld JS: Incidental finding of endolymphatic stromal myosis during luteinizing hormone releasing hormone agonist therapy for suspected benign uterine myomata: A case report., J Reprod Med Obstet Gynecol 1992:37:980-982.
47. Gatti D., Falsetti L., Viani A, Gaslaldi A: Uterine fibromyoma and sterility: Role of myomectomy., Acta Eur Fertil 1989:20:11-13.